Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The history now shows a new revision entry (v3.6.3) and the previous entry (v3.6.2) is removed, updating the page's revision history to reflect a recent change.
    Difference
    0.1%
    Check dated 2026-07-03T21:48:14.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous v3.6.0 in the page header, indicating the current page version has been updated. This reflects maintenance of the study history page rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-26T22:30:03.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer looking for participants, indicating enrollment has ceased. The record version is updated to v3.6.0, replacing the previous v3.5.5 revision.
    Difference
    0.3%
    Check dated 2026-06-12T13:25:48.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.5 was added to the history, and the previous v3.5.4 entry was removed from the listing, reflecting an update to the record.
    Difference
    0.1%
    Check dated 2026-06-05T08:26:35.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the study's record history, replacing the previous v3.5.3 entry. This reflects a minor update to the page's version metadata and does not affect study content or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:10:43.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page’s interface/version indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software/UI revision rather than any substantive update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:41.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.